11 Sources of evidence considered by the Committee

11 Sources of evidence considered by the Committee

The diagnostics assessment report was prepared by Kleijnen Systematic Reviews Ltd:

  • Riemsma R, Corro Ramos I, Birnie R et al. Type 1 diabetes: Integrated sensor‑augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo system and Vibe and G4 PLATINUM CGM system), a systematic review and economic evaluation. February 2015.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturers of technologies included in the final scope:

  • Medtronic Limited

  • Dexcom

  • Johnson & Johnson/Animas

Other commercial organisations:

  • Cellnovo Ltd

  • OmniPod

  • Roche Diagnostics

Professional groups and patient/carer groups:

  • Royal College of Physicians

  • Royal College of Pathologists

  • Dose Adjustment for Normal Eating (DAFNE)

  • Diabetes Inpatient Specialist Nurse UK Group

  • Juvenile Diabetes Research Foundation (JDRF)

  • INPUT Patient Advocacy

  • Diabetes UK

Research groups:

  • University of Southampton

  • Institute of Metabolic Science, University of Cambridge

Associated guideline groups:

None

Others:

  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government

  • BIVDA

  • Advanced Therapeutics UK Limited

  • National Institute for Health and Care Excellence (NICE)